IL81569A - 2-substituted quinoline dioic acids and pharmaceutical compositions containing them - Google Patents

2-substituted quinoline dioic acids and pharmaceutical compositions containing them

Info

Publication number
IL81569A
IL81569A IL81569A IL8156987A IL81569A IL 81569 A IL81569 A IL 81569A IL 81569 A IL81569 A IL 81569A IL 8156987 A IL8156987 A IL 8156987A IL 81569 A IL81569 A IL 81569A
Authority
IL
Israel
Prior art keywords
substd
opt
alkyl
benzyl
phenyl
Prior art date
Application number
IL81569A
Other languages
English (en)
Other versions
IL81569A0 (en
Original Assignee
Merck Frosst Canada Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Frosst Canada Inc filed Critical Merck Frosst Canada Inc
Publication of IL81569A0 publication Critical patent/IL81569A0/xx
Publication of IL81569A publication Critical patent/IL81569A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/18Halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/36Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL81569A 1986-02-14 1987-02-13 2-substituted quinoline dioic acids and pharmaceutical compositions containing them IL81569A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA501932 1986-02-14

Publications (2)

Publication Number Publication Date
IL81569A0 IL81569A0 (en) 1987-09-16
IL81569A true IL81569A (en) 1991-11-21

Family

ID=4132478

Family Applications (1)

Application Number Title Priority Date Filing Date
IL81569A IL81569A (en) 1986-02-14 1987-02-13 2-substituted quinoline dioic acids and pharmaceutical compositions containing them

Country Status (14)

Country Link
EP (1) EP0233763B1 (xx)
JP (1) JPH0686432B2 (xx)
KR (1) KR870007920A (xx)
AT (1) ATE60584T1 (xx)
AU (1) AU595286B2 (xx)
DE (1) DE3767730D1 (xx)
DK (1) DK168534B1 (xx)
ES (1) ES2031498T3 (xx)
GR (1) GR3001474T3 (xx)
IE (1) IE59889B1 (xx)
IL (1) IL81569A (xx)
NZ (1) NZ219249A (xx)
PT (1) PT84287B (xx)
ZA (1) ZA871064B (xx)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0271287A3 (en) * 1986-12-11 1990-06-13 Merck Frosst Canada Inc. Quinoline dioic acids and amides
US4920130A (en) * 1987-11-02 1990-04-24 Rorer Pharamceutical Corp. Quinoline derivatives and use thereof as antagonists of leukotriene D4
US4920132A (en) * 1987-11-03 1990-04-24 Rorer Pharmaceutical Corp. Quinoline derivatives and use thereof as antagonists of leukotriene D4
US4920131A (en) * 1987-11-03 1990-04-24 Rorer Pharmaceutical Corp. Quinoline derivatives and use thereof as antagonists of leukotriene D4
US5204358A (en) * 1987-11-25 1993-04-20 Merck Frosst Canada, Inc. Hetaryl styryl quinolines as leukotriene inhibitors
EP0318093A3 (en) * 1987-11-25 1990-12-05 Merck Frosst Canada Inc. Diarylquinoline diacids and their use as medicaments
CA1322004C (en) * 1987-11-25 1993-09-07 Merck Frosst Canada Incorporated Pyridyl styrene dialkanoic acids
US5104882A (en) * 1987-11-25 1992-04-14 Merck Frosst Canada, Inc. Diarylstrylquinoline diacids and pharmaceutical compositions thereof
GB8728051D0 (en) * 1987-12-01 1988-01-06 Leo Pharm Prod Ltd Chemical compounds
AU617386B2 (en) * 1987-12-01 1991-11-28 Leo Pharmaceutical Products Ltd. A/S (Lovens Kemiske Fabrik Produktionsaktieselskab) Substituted quinolines
US4883878A (en) * 1988-02-08 1989-11-28 Merck & Co. Inc. Process for unsymmetrical dithioacetals and dithioketals
EP0349062A1 (en) * 1988-06-27 1990-01-03 Merck Frosst Canada Inc. Quinoline ether alkanoic acid
US5070022A (en) * 1988-12-22 1991-12-03 Merck & Co., Inc. Enzymic process for preparing leukotriene antagonists
NZ233752A (en) * 1989-05-24 1993-05-26 Merck Frosst Canada Inc Substituted quinoline derivatives, preparation and pharmaceutical compositions thereof
US4996214A (en) * 1990-06-28 1991-02-26 Smithkline Beecham Corporation Quinolinyl substituted phenyl/thioalkanoic acid substituted propionic acids and leucotriene antagonist use thereof
DE19875039I2 (de) * 1990-10-12 2003-05-22 Merck Frosst Canada Inc Ungesaettigte Hydroxyalkylchinolinsaeuren als Leukotrien-Antagonisten
US5856322A (en) * 1990-10-12 1999-01-05 Merck Frosst Canada, Inc. Unsaturated hydroxyalkylquinoline acids as leukotriene antagonists
CA2053216C (en) * 1990-10-12 2003-04-08 Michel L. Belley Saturated hydroxyalkylquinoline acids as leukotriene antagonists
DE69113735T2 (de) * 1990-10-12 1996-06-13 Merck Frosst Canada Inc Hydroxyalkylchinolin Äther Säure als Leukotrien-Antagoniste.
US5266568A (en) * 1990-10-12 1993-11-30 Merck Frosst Canada, Inc. Hydroxyalkylquinoline ether acids as leukotriene antagonists
IE920499A1 (en) * 1991-02-21 1992-08-26 Merck Frosst Canada Inc Quinoline-containing ketoacids as leukotriene antagonists
US5212180A (en) * 1991-02-21 1993-05-18 Merck Frosst Canada, Inc. Quinoline-containing ketoacids as leukotriene antagonists
US5276044A (en) * 1991-08-14 1994-01-04 Allergan, Inc. Leukotriene receptor antagonist and antihistamine complex pharmaceutical compositions
US5270324A (en) * 1992-04-10 1993-12-14 Merck Frosst Canada, Inc. Fluorinated hydroxyalkylquinoline acids as leukotriene antagonists
AU4413893A (en) * 1992-06-22 1994-01-24 Merck Frosst Canada Inc. Fluorinated quinoline indoles as inhibitors of the biosynthesis of leukotrienes
US5964261A (en) * 1996-05-29 1999-10-12 Baxter International Inc. Implantation assembly
US20030216571A1 (en) * 1999-12-28 2003-11-20 Yoshiaki Kuroki Tricyclic compounds

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE56702B1 (en) * 1982-12-01 1991-11-06 Usv Pharma Corp Antiinflammatory antiallergic compounds
US4625034A (en) * 1985-02-04 1986-11-25 Usv Pharmaceutical Corp. 1,2-Dihydro; 1,2,3,4-tetrahydro; 5,8 dihydro; and 5,6,7,8-tetrahydroquinoline derivatives
ES8801209A1 (es) * 1985-06-18 1988-01-01 Merck Frosst Canada Inc Un procedimiento para la preparacion de quinolinas 2-sustituidas.

Also Published As

Publication number Publication date
JPS62258363A (ja) 1987-11-10
NZ219249A (en) 1990-07-26
ATE60584T1 (de) 1991-02-15
KR870007920A (ko) 1987-09-22
ES2031498T3 (es) 1992-12-16
PT84287B (pt) 1989-09-14
EP0233763B1 (en) 1991-01-30
EP0233763A3 (en) 1988-10-19
DK168534B1 (da) 1994-04-18
DK72287D0 (da) 1987-02-13
AU595286B2 (en) 1990-03-29
GR3001474T3 (en) 1992-10-08
ZA871064B (en) 1987-10-28
IE870334L (en) 1987-08-14
PT84287A (en) 1987-03-01
DE3767730D1 (de) 1991-03-07
EP0233763A2 (en) 1987-08-26
AU6871787A (en) 1987-08-20
DK72287A (da) 1987-08-15
IL81569A0 (en) 1987-09-16
IE59889B1 (en) 1994-04-20
JPH0686432B2 (ja) 1994-11-02

Similar Documents

Publication Publication Date Title
IL81569A (en) 2-substituted quinoline dioic acids and pharmaceutical compositions containing them
DK0382450T3 (da) Fremgangsmåde til fremstilling af mono- eller dicarboxylsyrematerialer substituerede med langkædet hydrocarbyl
DK207175A (da) Fremgangsmade til fremstilling af cephalosporiner med alfa-acylaminoeddikesyresidekede
IT1032781B (it) Procedimento per la costruzione di denti artificiali
BE834055A (fr) Raccord adaptateur perfectionne pour catheter
FR2340717A1 (fr) Procede pour remineraliser et immuniser l'email dentaire
BE837505A (fr) Procede pour la sequestration de l'oxygene dissous dans l'eau et compositions utilisables a cet effet
BE828957A (fr) Joint perfectionne pour turbo-machines
IT8248240A0 (it) Derivati di acidi fenil alifatico carbossilici, procedimento per laloro preparazione e composizioni farmaceutiche che li contengono
IT988272B (it) Procedimento per l eliminazione o per la lavorazione congiunta di residui di sali da tempra
BE801408A (fr) Seringue pour matiere de prise d'empreinte dentaire
FR2279509A1 (fr) Metal d'apport pour soudures
IT1048158B (it) Procedimento per preparare anidridin carbossiliche di amminoacidi
IT947509B (it) Procedimento per evitare screpola ture subsuperficiali durante la placcatura e la saldatura
IT1003700B (it) Giunto per unire elementi girevoli
IT1025674B (it) Procedimento per determinare il tenore di ossido in bagni fusi salini
IT8148730A0 (it) Composizioni farmaceutiche antibroncospastiche idrosolubili costituite da sali della teofillina con aminoacidi basici
GB1304174A (xx)
FR2280475A1 (fr) Metal d'apport pour soudure
IT8423278A0 (it) Dispositivo per l'adduzione di una prestabilita quantita' di additivo in una vasca d'acqua.
IT1001989B (it) Procedimento per la preparazione di lattici stabili ai sali e lattici cosi prodotti
IT1040561B (it) Procedimento ed apparecchiatura per la depurazione spinta di soluzioni acquose di sali metallici
IT8021098A0 (it) Sali del cefadroxil con aminoacidi
FR2131816A1 (en) Perchloric acid and salts - for clearing and disinfecting dental canals
IT1060378B (it) Procedimento per la preparazione di ammidi alcaline

Legal Events

Date Code Title Description
KB Patent renewed
HS Change of address for service
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees